These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 228106)

  • 1. Suppression of the immune response in tumor-bearing mice. II. Characterization of adherent suppressor cells.
    Bluestone JA; Lopez C
    J Natl Cancer Inst; 1979 Nov; 63(5):1221-7. PubMed ID: 228106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the immune response in tumor-bearing mice. I. Response to virus-producing tumor cells and non-virus-producing tumor cells.
    Bluestone JA; Lopez C
    J Natl Cancer Inst; 1979 Nov; 63(5):1215-20. PubMed ID: 228105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.
    Fujii T; Igarashi T; Kishimoto S
    J Natl Cancer Inst; 1987 Mar; 78(3):509-17. PubMed ID: 2950265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell-mediated immunity to oncornavirus-induced tumors. III. Specific and nonspecific suppression in tumor-bearing mice.
    Plater C; Debré P; Leclerc JC
    Eur J Immunol; 1981 Jan; 11(1):39-44. PubMed ID: 6452278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of gp70-specific suppressor T-cells in mice inoculated with virus-producing tumor cells.
    Bluestone JA; Lopez C
    J Natl Cancer Inst; 1982 Oct; 69(4):953-9. PubMed ID: 6214655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages.
    Elgert KD; Farrar WL
    J Immunol; 1978 Apr; 120(4):1345-53. PubMed ID: 305939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Defects in cell-mediated and humoral immunity in tumor-bearing mice. Evidence and characterization of suppressor cells ].
    Siegl E; Günther J; Schulze HA; Brock J
    Allerg Immunol (Leipz); 1981; 27(3):153-61. PubMed ID: 6214936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
    Ting CC; Rodrigues D
    J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay.
    Raina S; Russo AJ; Jenkins D; Goldrosen MH
    Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG; Burger CJ; Elgert KD
    J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased susceptibility to tumor cell immunosuppressive effect in tumor-bearing mice.
    Ting CC; Rodrigues D
    J Natl Cancer Inst; 1980 Jul; 65(1):205-9. PubMed ID: 6967124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective immunomodulation by the antineoplastic agent mitoxantrone. II. Nonspecific adherent suppressor cells derived from mitoxantrone-treated mice.
    Fidler JM; DeJoy SQ; Smith FR; Gibbons JJ
    J Immunol; 1986 Apr; 136(8):2747-54. PubMed ID: 2937837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matching of chemotherapy to mouse strain and lymphoid tumor type to prevent tumor-induced suppression of specific T- and B-cell functions.
    Faanes RB; Merluzzi VJ; Williams N; Tarnowski GS; Ralph P
    Cancer Res; 1979 Nov; 39(11):4564-74. PubMed ID: 315269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of host antitumor defense mechanisms in mice by progressively growing tumor.
    Maccubbin DL; Mace KF; Ehrke MJ; Mihich E
    Cancer Res; 1989 Aug; 49(15):4216-24. PubMed ID: 2525950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of a chemically-induced sarcoma in rats: characterization of the effector T cell subset and nature of suppression.
    Fernandez-Cruz E; Gilman SC; Feldman JD
    J Immunol; 1982 Mar; 128(3):1112-7. PubMed ID: 6460058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of mouse migration inhibitory factor (MIF) production form MSV-immune lymphocytes by soluble tumor-associated antigen: requirement for histocompatible macrophages.
    Landolfo S; Herberman RB; Holden HT
    J Immunol; 1977 Apr; 118(4):1244-8. PubMed ID: 191532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1.
    Wong CY; Woodruff JJ; Woodruff JF
    J Immunol; 1977 Apr; 118(4):1165-9. PubMed ID: 300400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of cytotoxic T lymphocyte development by a minor stimulating locus-induced suppressor cascade that involves Lyt-1+ suppressor T cells, IA- macrophages, and their factors.
    Chow KP; Battisto JR
    J Immunol; 1988 Feb; 140(4):1005-13. PubMed ID: 2963857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.